₹155.00
Offers Applicable
- Free shipping on all India orders above 1499₹
- Buy More Medicine
Description
SBL Nixocid Tabs
The pH of the stomach can be disturbed due to alcoholism, smoking, stress, anxiety, spicy foods, irregular eating habits, and prolonged ingestion of NSAIDs leading to hyperacidity. Nixocid relieves hyperacidity and associated symptoms by normalizing the pH level of the stomach.
Indications of SBL Nixocid Tabs:
Heartburn, sour eructation, flatulence, burning sensation in the stomach, gastritis, gastric ulcers.
The action of Composition used in SBL Nixocid Tabs:
Natrum phosphoricum – 3x:Â Natrum Phos is the pH balancer of acid conditions. A lack of proper balance of the alkaline Natrum Phosphate in gastric enzyme activity will allow fermentations and retard (slowdown) digestion. It regulates the Bile production. Natrum Phos helps restore enzyme balance and relieve acidity, heartburn, dyspepsia, gas, distention or bloating, flatulence, etc.
Lycopodium clavatum – 3x:Â Â Dyspepsia due to farinaceous and fermentable food, cabbage, beans, Eating ever so little creates fullness.
Carbo vegetabilis – 6x:Â Eructations after eating and drinking. Temporary relief from belching. Rancid, sour, or putrid eructations. Eructations after eating and drinking. Temporary relief from belching. Rancid, sour, or putrid eructations.
Robinia pseudacacia – 3x:Â The gastric symptoms with acidity are well-marked. The acidity of Robinia is accompanied by a frontal headache. Intensely acrid eructations.
Dosage/Directions for use in SBL Nixocid Tabs:
Adults:Â 2 tablets 3-4 times a day. In acute conditions 2-3 hourly.
Children: Half of the adult’s dose.
Terms and Conditions
Homeopathic products have several uses and should be taken on the basis of symptom similarity. Results may vary depending upon the conditions.
Additional information
Weight | 90 g |
---|---|
Dimensions | 4.5 × 4.5 × 7.5 cm |
Brands | SBL |
Diseases | Acidity, Flatulence, Gastritis, Heart Burn, Hyperacidity |
Variety | Tablet |
Reviews
There are no reviews yet.